| Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal F Yi, L Pereira, JA Hoffman, BR Shy, CM Yuen, DR Liu, BJ Merrill Nature cell biology 13 (7), 762-770, 2011 | 344 | 2011 |
| Test performance evaluation of SARS-CoV-2 serological assays JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174, 2020 | 267 | 2020 |
| Evaluation of SARS-CoV-2 serology assays reveals a range of test performance JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174-1183, 2020 | 261 | 2020 |
| Magnitude and kinetics of anti–severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity KL Lynch, JD Whitman, NP Lacanienta, EW Beckerdite, SA Kastner, ... Clinical Infectious Diseases 72 (2), 301-308, 2021 | 256 | 2021 |
| SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood DL Ng, GM Goldgof, BR Shy, AG Levine, J Balcerek, SP Bapat, J Prostko, ... Nature communications 11 (1), 4698, 2020 | 198 | 2020 |
| Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering JR Hamilton, CA Tsuchida, DN Nguyen, BR Shy, ER McGarrigle, ... Cell reports 35 (9), 2021 | 146 | 2021 |
| High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails BR Shy, VS Vykunta, A Ha, A Talbot, TL Roth, DN Nguyen, WG Pfeifer, ... Nature biotechnology 41 (4), 521-531, 2023 | 139 | 2023 |
| Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling BR Shy, CI Wu, GF Khramtsova, JY Zhang, OI Olopade, KH Goss, ... Cell reports 4 (1), 1-9, 2013 | 127 | 2013 |
| Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3–β-catenin interaction CI Wu, JA Hoffman, BR Shy, EM Ford, E Fuchs, H Nguyen, BJ Merrill Development 139 (12), 2118-2129, 2012 | 116 | 2012 |
| MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot–Marie–Tooth disease type 1B MAC Saporta, BR Shy, A Patzko, Y Bai, M Pennuto, C Ferri, E Tinelli, ... Brain 135 (7), 2032-2047, 2012 | 78 | 2012 |
| Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes DV Foss, JJ Muldoon, DN Nguyen, D Carr, SU Sahu, JM Hunsinger, ... Nature biomedical engineering 7 (5), 647-660, 2023 | 75 | 2023 |
| Co-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells BR Shy, MS MacDougall, R Clarke, BJ Merrill Nucleic acids research 44 (16), 7997-8010, 2016 | 75 | 2016 |
| Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies DB Goodman, CS Azimi, K Kearns, A Talbot, K Garakani, J Garcia, ... Science translational medicine 14 (670), eabm1463, 2022 | 60 | 2022 |
| CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells E Lin-Shiao, WG Pfeifer, BR Shy, M Saffari Doost, E Chen, VS Vykunta, ... Nucleic acids research 50 (3), 1256-1268, 2022 | 57 | 2022 |
| Base-editing mutagenesis maps alleles to tune human T cell functions R Schmidt, CC Ward, R Dajani, Z Armour-Garb, M Ota, V Allain, ... Nature 625 (7996), 805-812, 2024 | 34 | 2024 |
| Test performance evaluation of SARS-CoV-2 serological assays. MedRxiv. 2020 JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Publisher Full Text, 2020 | 19 | 2020 |
| Polyclonal regulatory T cell manufacturing under cGMP: a decade of experience J Balcerek, BR Shy, AL Putnam, LM Masiello, A Lares, F Dekovic, ... Frontiers in Immunology 12, 744763, 2021 | 18 | 2021 |
| Hybrid ssDNA repair templates enable high yield genome engineering in primary cells for disease modeling and cell therapy manufacturing BR Shy, V Vykunta, A Ha, TL Roth, A Talbot, DN Nguyen, YY Chen, ... BioRxiv, 2021.09. 02.458799, 2021 | 15 | 2021 |
| Bidirectional epigenetic editing reveals hierarchies in gene regulation NM Pacalin, Z Steinhart, Q Shi, JA Belk, D Dorovskyi, K Kraft, KR Parker, ... Nature biotechnology, 1-14, 2024 | 9 | 2024 |
| Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity [Internet]. Infectious Diseases (except HIV/AIDS). medRxiv; 2020 KL Lynch, JD Whitman, NP Lacanienta, EW Beckerdite, SA Kastner, ... | 5 | |